METASTATIC PANCREATIC CANCER

Clinical trials for METASTATIC PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for METASTATIC PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 14 Not yet recruiting 1 Not yet finished but already full! 10 Completed 2 Terminated 5

New hope for tough pancreatic cancer: targeted drug enters final testing

Disease control Not yet recruiting

This study is testing whether a new targeted drug called GFH375 works better than standard chemotherapy for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12D mutation) and has worsened after previous treatment. About 320 participants will be ran…

Matched conditions: METASTATIC PANCREATIC CANCER

Phase: PHASE3 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

METASTATIC PANCREATIC CANCER

Get alerted when new METASTATIC PANCREATIC CANCER trials appear

New hope for tough pancreatic cancer: targeted drug enters final testing